TRXADE GROUP MEDS 深 沪
等待开盘 10-02 09:30:00 美东时间
7.59
0.000
0.00%
华盛通- 最 高--
- 今 开--
- 成交量 0股
- 最 低 --
- 昨 收 7.59
- 总市值 914.60万
- 52周最高 35.06
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 -5.81
- 委 比 0.00%
- 总股本 120.50万
- 历史最高 164.50
- 量 比 0
- 振 幅 0.00%
- 历史最低 -5.81
- 每 手 1
- 风险率 0.17%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Revolution Medicines Announces Key Leadership Additions, including Alan Sandler, M.D. as Chief Development Officer
Revolution Medicines appoints Alan Sandler, M.D., as Chief Development Officer and adds regional leaders to support global commercial capabilities. Dr. Sandler, a recognized oncology leader, brings extensive experience in drug development. The company also appointed Alicia Gardner and Gerwin Winter as U.S. and European regional general managers to prepare for potential approvals and launches of RAS(ON) inhibitors, including daraxonrasib, targetin...
09-29 13:00
TRxADE Health, Inc. Announces Name Change To Scienture Holdings, Inc. And Ticker Symbol Change To "SCNX"
TRxADE Health, Inc. today announced that it changed its name and ticker symbol to "Scienture Holdings, Inc." and "SCNX", respectively, and that the business will continue as a Nasdaq-listed company. TAMPA, FL, Sept.
2024-09-24 20:29
Trxade Health announces name change to Scienture Holdings
TRxADE Health (NASDAQ:SCNX) has announced that it changed its name and ticker symbol to “Scienture Holdings” and “SCNX”, respectively, and that the business will continue as a Nasdaq-listed company. S...
2024-09-24 20:05
Trxade Group’s Strategic Merger and Rebranding as Scienture Holdings
Trxade Group (MEDS) has issued an announcement. On July 25, 2024, TRxADE HEALTH...
2024-08-01 05:51
Trxade Health acquires Scienture in all-stock transaction valued at $103M
TRxADE HEALTH (NASDAQ:MEDS) and Scienture has announced the closing of TRxADE’s business combination with Scienture in an all-stock transaction. TRxADE acquired all of Scienture’s assets in exchange f...
2024-07-26 22:47
Trxade Group declares $1.50 special dividend
Trxade Group (NASDAQ:MEDS) declares $1.50/share special dividend. Payable July 24; for shareholders of record July 19; ex-div July 19. See MEDS Dividend Scorecard, Yield Chart, & Dividend Growth. More...
2024-07-09 20:06
TRxADE HEALTH shares are trading higher. The company reported Q1 financial results.
TRxADE HEALTH shares are trading higher. The company reported Q1 financial resu...
2024-06-27 20:15
Trxade Health Q1 EPS $(6.40) Down From $(0.45) YoY
Trxade Health (NASDAQ:MEDS) reported quarterly losses of $(6.40) per share. This is a 1322.22 percent decrease over losses of $(0.45) per share from the same period last year.
2024-06-27 20:03
TRxADE HEALTH receives Nasdaq notice regarding late filing of annual report
TRxADE HEALTH (NASDAQ:MEDS) on Tuesday said it has received a notice from Nasdaq, indicating that because the company had not yet filed its Annual Report on Form 10-K for the 2023 fiscal year, it was ...
2024-04-24 05:26
CGC, CYTO and IDN are among mid-day movers
Gainers: Landos Biopharma (LABP) +171%. MoneyHero (MNY) +49%. Next. (EGOX) +50%. KULR Technology (KULR) +42%. Intellicheck (IDN) +31%. Altamira Therapeutics (CYTO) +31%. Nkarta (NKTX) +26%. X.T.L....
2024-03-26 01:25
